Hints and tips:
Related Special Reports
...Lilly uses online pharmacies Truepill and Amazon Pharmacy to dispense its medicines, in a move driven in part by huge demand for its popular weight-loss drug....
...Eli Lilly, the world’s largest drugmaker by market value, has struck a deal that will allow Amazon’s online pharmacy business to dispense medication, including its hugely popular weight loss injection pen...
...Adam Fein, president of Drug Channels Institute, said Amazon Pharmacy “continues to garner attention . . . beyond its actual impact on the pharmacy industry”....
...“Is the biosimilar market a failure with respect to these pharmacy benefit drugs like Humira?...
...Ain Holdings, the largest prescription drugstore chain with more than 1,200 dispensing pharmacies in Japan, has become the latest target....
...The higher number of shortages has also led to the government reimbursing pharmacies for buying drugs above their standard cost more frequently....
...Ecuador has reached a deal with the IMF worth about $4bn in financing over four years, as the South American country seeks to loosen its constrained finances amid a crackdown on drug traffickers....
...The reforms will encourage pharmacy benefit managers to limit use of the most expensive drugs. That will hit companies like AstraZeneca, maker of oral cancer drugs such as Tagrisso....
...Eli Lilly last week announced a deal to buy a Wisconsin-based production facility for filling its injectable pens from Nexus Pharmaceuticals....
...California has taken a first step to push down pharmaceutical prices in the US state, striking a deal with the maker of a drug that can reverse opioid overdoses to purchase the medicine at a large discount...
...A weight-loss drug licensed by Boehringer Ingelheim from Danish biotech Zealand Pharma has had positive results in liver disease trials, while Novo Nordisk is looking at the effect of its weight-loss drug...
...But Eli Lilly declined to say how much of the product would be available in Britain, or which pharmacies will stock the product. Patients in Northern Ireland will not have access to the pen....
...Chief executive Lars Fruergaard Jørgensen told the Financial Times this month that it was assessing deals for biotech companies with mid-stage drugs....
...The problem is recurrent and widespread: in 2022 and 2023, national pharmacy bodies across 26 European countries all reported shortages, with the picture worsening last year....
...By these dubious criteria, it is impossible to deny that Potter Payper is the real deal....
...It follows a surge in the drug’s popularity and a lack of supplies, which has prompted patients to turn to illegal online pharmacies....
...Shares in CVS Health fell more than 8.1 per cent at the close on Thursday after a decision was made by the insurer to drop its Caremark unit as its main pharmacy benefit manager (PBM)....
...Scientists have invented a potential drug candidate that successfully combats antibiotic-resistant “superbugs” in non-human tests, according to research....
...The insurer said the US drug purchasing system, which is dominated by PBMs — essentially drug middlemen — is “broken”, and that it expects to save $500mn in annual drug costs with its new model....
...The ImmunoGen deal came four decades after the company started working on the first generation of ADCs....
...This deal is being forced on Japan by demographics, but the idea applies more widely....
...Roche and AstraZeneca have already struck deals to buy or license early stage weight-loss drugs....
...Jesse Mark, head of equity capital markets at Jefferies, said the most notable shift was an increase in “opportunistic” deals from companies whose fundraising was not linked to encouraging drug trial data...
...Medical supplies, from anaesthesia to everyday basic drugs, are scarce....
International Edition